Table 1.
Summary of AED efficacy in different absence seizure types
TAS | AAS | EMA | MA | Main advantage | Main disadvantage | |
---|---|---|---|---|---|---|
Valproate | +++ | ++ | ++ | ++ | Effective against all seizure types | Should be avoided in girls of childbearing age |
Ethosuximide | +++ | ++ | +? | ++ | Minimal cognitive side effects | ineffective against tonic-clonic seizures |
Lamotrigine | ++ | + | +? | +? | Favorable tolerability profile | Long dose titration |
Levetiracetam | + | ? | ++ | ? | Favorable tolerability profile | |
Rufinamide | ? | ++ | ? | ++? | Effective against drop-attacks in LGS | Limited experience |
Benzodiazepine | ++ | ++ (CLB) | ++ (CNZ) | ? | Rapidly effective | Risk of dependence and habituation |
Notes: Degree of efficacy: +++ high, ++ moderate, + weak, ? unknown.
Abbreviations: TAS, typical absence seizures; AAS, atypical absence seizures; EMA, eyelid myoclonia with absences; MA, myoclonic absences; CLB, clobazam, CNZ, clonazepam; LGS, Lennox-Gastaut Syndrome; AED, antiepileptic drug.